Vivos Therapeutics, Inc. (VVOS): Cash & Equivalents
$2.03M
As of 2025-12-31
$1.77M
As of 2026-06-30
-16.8%
3-year compound annual growth
-35.5%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.03M | -67.6% | 2026-04-15, Balance as of period end |
| 2024-12-31 | $6.26M | +281.0% | 2026-04-15, Balance as of period end |
| 2023-12-31 | $1.64M | -53.3% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $3.52M | -85.4% | 2024-07-30, Balance as of period end |
| 2021-12-31 | $24.03M | +32.0% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $18.21M | n/m | 2022-03-31, Balance as of period end |
| 2019-12-31 | $469.4K | n/a | 2021-03-25, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | $2.03M | -67.6% |
| Nephros Inc (NEPH) | 2025-12-31 | $5.40M | +43.6% |
| Profound Medical Corp. (PROF) | 2025-12-31 | $59.72M | +8.8% |
| Biotricity Inc. (BTCY) | 2026-03-31 | $149.8K | -59.0% |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | $2.40M | -55.4% |
| Spectral AI, Inc. (MDAI) | 2025-12-31 | $15.40M | +196.2% |
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | $5.41M | -64.8% |
| DarioHealth Corp. (DRIO) | 2025-12-31 | $21.80M | -21.5% |
| Baird Medical Investment Holdings Ltd (BDMD) | 2025-12-31 | $178.3K | -94.0% |
Compare VVOS, NEPH, PROF, BTCY side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗